AIDS-related Kaposi's sarcoma can occur during peginterferon-α and ribavirin therapy for chronic hepatitis C infection.

about

AIDS-related Kaposi's sarcoma can occur during peginterferon-α and ribavirin therapy for chronic hepatitis C infection.

Item

http://www.wikidata.org/entity/Q50555079

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

AIDS-related Kaposi's sarcoma ...... chronic hepatitis C infection.

@en

AIDS-related Kaposi's sarcoma ...... chronic hepatitis C infection.

@nl

type

Item

label

AIDS-related Kaposi's sarcoma ...... chronic hepatitis C infection.

@en

AIDS-related Kaposi's sarcoma ...... chronic hepatitis C infection.

@nl

prefLabel

AIDS-related Kaposi's sarcoma ...... chronic hepatitis C infection.

@en

AIDS-related Kaposi's sarcoma ...... chronic hepatitis C infection.

@nl

P1476

AIDS-related Kaposi's sarcoma ...... chronic hepatitis C infection.

@en

P2093

Constance Delaugerre

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Molina

http://www.w3.org/2001/XMLSchema#string

Juliette Pavie

http://www.w3.org/2001/XMLSchema#string

Victoire de Lastours

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

Risk of cancers during interrupted antiretroviral therapy in the SMART study.

AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?

Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans.

Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment.

Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon.

Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha.

Maintaining Antiretroviral Therapy Reduces the Risk of AIDS-Defining Events in Patients with Uncontrolled Viral Replication and Profound Immunodeficiency

P304

9-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1545109711420875

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51657983

http://www.w3.org/2001/XMLSchema#string

P698

21934116

http://www.w3.org/2001/XMLSchema#string